Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis

17 Jul 2002

Abstract excerpt

Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor cells, it shows the existence of free-circulating tumor-associated DNA. The objective of our study was to assess the prognostic value of free-circulating tumor-associated DNA in colorectal cancer patients' plasma. The first step...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12124803
DOI: 10.1002/ijc.10526

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosisPMID 12124803Read ↗

Circulating free tumor DNA and colorectal cancer.Semantic proximity Read ↗

Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer.Semantic proximity Read ↗

Quantitative Analysis of Plasma DNA in Colorectal Cancer PatientsSemantic proximity Read ↗

Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast CancerSemantic proximity Read ↗

Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.Semantic proximity Read ↗

Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian CarcinomaSemantic proximity Read ↗

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal CancerSemantic proximity Read ↗

The role of plasma cell-free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patientsSemantic proximity Read ↗

Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer.Semantic proximity Read ↗

Methylated free‐circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerSemantic proximity Read ↗

Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRA.Semantic proximity Read ↗

RASSF1Apromoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.